SEC Form 4 · accession 0001144204-16-115995
DERMA SCIENCES, INC. · DSCI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Barry Wolfenson
Other
Period of report
Jul 31, 2016
Accepted (ET)
Aug 2, 2016 · 4:56 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000892160
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F2,F1 | $13.39 | Feb 14, 2014 | A | 5,875 | A | Feb 14, 2014 | Feb 14, 2024 | Common Stock | 5,875 | 0 | D |
| Stock Option (right to buy)F2,F1 | $8.83 | Feb 12, 2015 | A | 6,500 | A | Feb 12, 2015 | Feb 12, 2025 | Common Stock | 6,500 | 0 | D |
| Stock Option (right to buy)F2,F1 | $3.30 | Mar 2, 2016 | A | 12,000 | A | Mar 2, 2016 | Mar 2, 2026 | Common Stock | 12,000 | 0 | D |
Explanation of responses
- F1The options, granted pursuant to the issuer's equity incentive plan and which vested as to 25% on the grant date and as to an additional 25% for each of the following three years, vested on an accelerated basis. Any remaining equity awards previously reported that did not vest prior to July 31, 2016 were forfeited effective as of such date.
- F2The options were originally granted in consideration of the reporting person's past services to the issuer and without payment of cash consideration.
Remarks
Former Group President, Advanced Wound Care